Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

345 ARTÍCULOS , VIENDO DEL 301 AL 315

Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease

Li C, Ebrahimi A, Schluesener H.

Ageing Res Rev. 2013 Jan;12(1):116-40. doi: 10.1016/j.arr.2012.09.002. Epub 2012 Sep 12.

Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?

Reddy PH.

Biochim Biophys Acta. 2013 Jan;1832(1):67-75. doi: 10.1016/j.bbadis.2012.09.003. Epub 2012 Sep 17.

Na⁺-K⁺-ATPase, a potent neuroprotective modulator against Alzheimer disease

Zhang LN, Sun YJ, Pan S, Li JX, Qu YE, Li Y, Wang YL, Gao ZB.

Fundam Clin Pharmacol. 2013 Feb;27(1):96-103. doi: 10.1111/fcp.12000. Epub 2012 Oct 3.

Effects of pharmacological agents, sleep deprivation, hypoxia and transcranial magnetic stimulation on electroencephalographic rhythms in rodents: towards translational challenge models for drug discovery in Alzheimer's disease

Babiloni C, Infarinato F, Aujard F, Bastlund JF, Bentivoglio M, Bertini G, Del Percio C, Fabene PF, Forloni G, Herrero Ezquerro MT, Noè FM, Pifferi F, Ros-Bernal F, Christensen DZ, Dix S, Richardson JC, Lamberty Y, Drinkenburg W, Rossini PM.

Clin Neurophysiol. 2013 Mar;124(3):437-51. doi: 10.1016/j.clinph.2012.07.023. Epub 2012 Oct 4.

Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain

Sultana R, Perluigi M, Butterfield DA.

Free Radic Biol Med. 2013 Sep;62:157-169. doi: 10.1016/j.freeradbiomed.2012.09.027. Epub 2012 Oct 5.

Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients

Babiloni C, Del Percio C, Bordet R, Bourriez JL, Bentivoglio M, Payoux P, Derambure P, Dix S, Infarinato F, Lizio R, Triggiani AI, Richardson JC, Rossini PM.

Clin Neurophysiol. 2013 May;124(5):837-50. doi: 10.1016/j.clinph.2012.09.017. Epub 2012 Oct 23.

Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease

Gauthier S, Molinuevo JL.

Alzheimers Dement. 2013 May;9(3):326-31. doi: 10.1016/j.jalz.2011.11.005. Epub 2012 Oct 27.

A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse)

Chen Y, Liang Z, Blanchard J, Dai CL, Sun S, Lee MH, Grundke-Iqbal I, Iqbal K, Liu F, Gong CX.

Mol Neurobiol. 2013 Apr;47(2):711-25. doi: 10.1007/s12035-012-8375-5. Epub 2012 Nov 14.

Combination of Aβ clearance and neurotrophic factors as a potential treatment for Alzheimer's disease

Lin LF, Liao MJ, Xue XY, Zhang W, Yan L, Cai L, Zhou XW, Zhou X, Luo HM.

Neurosci Bull. 2013 Feb;29(1):111-20. doi: 10.1007/s12264-012-1287-6. Epub 2012 Nov 21.

Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model

Hyde C, Peters J, Bond M, Rogers G, Hoyle M, Anderson R, Jeffreys M, Davis S, Thokala P, Moxham T.

Age Ageing. 2013 Jan;42(1):14-20. doi: 10.1093/ageing/afs165. Epub 2012 Nov 22.

Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer's disease and some pro-oxidant induced oxidative stress in rats' brain-in vitro

Oboh G, Agunloye OM, Akinyemi AJ, Ademiluyi AO, Adefegha SA.

Neurochem Res. 2013 Feb;38(2):413-9. doi: 10.1007/s11064-012-0935-6. Epub 2012 Nov 27.

Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding

Wong WB, Lin VW, Boudreau D, Devine EB.

Pharmacoepidemiol Drug Saf. 2013 Apr;22(4):345-58. doi: 10.1002/pds.3381. Epub 2012 Dec 6.

Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors

Bolea I, Gella A, Unzeta M.

J Neural Transm (Vienna). 2013 Jun;120(6):893-902. doi: 10.1007/s00702-012-0948-y. Epub 2012 Dec 13.

Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways

Silva T, Teixeira J, Remião F, Borges F.

Angew Chem Int Ed Engl. 2013 Jan 21;52(4):1110-21. doi: 10.1002/anie.201204964. Epub 2012 Dec 20.

Effectiveness of antidementia drugs in delaying Alzheimer's disease progression

Rountree SD, Atri A, Lopez OL, Doody RS.

Alzheimers Dement. 2013 May;9(3):338-45. doi: 10.1016/j.jalz.2012.01.002. Epub 2012 Oct 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias